Skip to main content
Clinical Trials/CTRI/2018/05/013843
CTRI/2018/05/013843Not yet recruitingPhase 4

Comparative clinical and ultrasonographic evaluation of the efficiency of Placentrex with Dexamethasone & Hyaluronidase with Dexamethasone in the treatment of Oral Submucous Fibrosis- A randomized Control Trial

Dr Sosa George0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Individuals clinically diagnosed with Oral Submucous Fibrosis with palpable bands in the oral cavity
  • 2)OSMF patients with mouth opening greater than 25mm
  • 3)Individuals with willingness to quit the habit that caused the disease
  • 4)Individuals willingly consenting to take part in the study
  • 5)No previous history of treatment for oral submucous fibrosis
  • 6)no other concurrent oral lesions

Exclusion Criteria

  • 1)Patients who are unwilling to quit the habit that caused the disease.
  • 2)Patients unwilling to consent for the study.
  • 3)Previously treated Oral Submucous Fibrosis.
  • 4)Currently under treatment for Oral Submucous Fibrosis.
  • 5)Presence of other concurrent oral premalignant lesions.
  • 6)Health status which makes the patient not a feasible candidate for the trial.

Investigators

Sponsor
Dr Sosa George

Similar Trials